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Developing animals are more sensitive than adults to acute cholinergic toxicity from
anticholinesterases, including organophosphorus pesticides, when administered in a laboratory
setting. It is also possible that these agents adversely affect the process of neural development
itself, leading to permanent deficits in the architecture of the central and peripheral nervous
systems. Recent observations indicate that organophosphorus exposure can affect DNA synthesis
and cell survival in neonatal rat brain. New evidence that acetylcholinesterase may have a direct
role in neuronal differentiation provides additional grounds for interest in the developmental toxicity
of anticholinesterases. For example, correlative anatomic studies show that transient bursts of
acetylcholinesterase expression often coincide with periods of axonal outgrowth in maturing avian,
rodent, and primate brain. Some selective cholinesterase inhibitors effectively suppress neurite
outgrowth in model systems like differentiating neuroblastoma cells and explanted sensory
ganglia. When enzyme expression is altered by genetic engineering, acetylcholinesterase levels on
the outer surface of transfected neurons correlate with ability to extend neurites. Certain of these
"morphogenic" effects may depend on protein-protein interactions rather than catalytic
acetylcholinesterase activity. Nonetheless, it remains possible that some pesticides interfere with
important developmental functions of the cholinesterase enzyme family. - Environ Health
Perspect 107(Suppl 1):59-64 (1999). http://ehpnetl.niehs.nih.gov/docs/1999/Suppl-1/
5964brimijoin/abstract.html
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Carbamate and organophosphorus pesticides
probably owe both their agricultural effec-
tiveness and their primary toxicity to inhi-
bition ofacetylcholinesterase (AChE, EC
3.1.1.7). The toxicology of anticholine-
sterase agents in adults is relatively well
understood, but less is known about their
effects on the young. When considering
the developmental toxicology of anti-
cholinesterase agents, three questions need
to be asked: a) Are immature organisms
likely to be more sensitive than adults to
acute anticholinesterase toxicity, experienc-
ing greater dysfunction at lower levels of
exposure? b) Could anticholinesterases
cause lasting neurochemical and neuro-
behavioral deficits in younger organisms?
c) Might anticholinesterases even disturb
the structure ofemerging nervous systems
byaffecting development itself?
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A short answer to all three questions is
that we know too little to draw firm con-
clusions, and hard data are notably scarce.
Nonetheless, there are theoretical grounds
for hypothesizing that anticholinesterases
might be more dangerous in the young
than previously suspected. One reason for
concern is new evidence that AChE and
the related enzyme, butyrylcholinesterase
(BChE, EC 3.1.1.8), also targeted by pesti-
cides, may both have roles in neurologic
development. That evidence will be
addressed in the next section. First we
should review current data on the sensitiv-
ity ofyoung animals to toxicity from envi-
ronmentally relevant anticholinesterase
pesticides. Chlorpyrifos, a widely used
organophosphate precursor, is an interest-
ing case in point. Neuropathologic studies
used to support chlorpyrifos registration
with the U.S. Environmental Protection
Agency uncovered no evidence of terato-
genicity or gross damage to brain structure.
However, sophisticated investigations
directed at subtler developmental effects
have only begun in the past fewyears.
New results do not disprove the idea
that chlorpyrifos is relatively benign, at least
in adults, but they raise concerns about its
effects on the young. It is now clear that
newborn rodents are more sensitive than
adults to the acute toxicity ofchlorpyrifos
in pharmacologic doses (1-3). Specifically,
rats given chlorpyrifos at postnatal day 17
show behavioral changes, ChE inhibition,
and downregulation ofmuscarinic receptors
in the brain at single oral doses of 15
mg/kg, 5-fold lower than required for simi-
lar effects in adults (4). More disturbing are
two reports of biochemical and morpho-
logic effects in the newborn rat from chlor-
pyrifos in very low doses evoking no
systemic toxicity. Although AChE activity
was not determined, one study showed
depressed DNA synthesis throughout the
brain when day-old rats received 2 mg/kg
chlorpyrifos subcutaneously (5). Another
demonstrated net loss of neurons in the
forebrain of 2-week-old rats treated with
only 1 mg/kg (6).
Heightened chlorpyrifos sensitivity in
newborns does not reflect postnatal persis-
tence of an intrinsically susceptible,
"immature" AChE (7). Instead the expla-
nation appears to be a relative deficiency of
organophosphorus hydrolase enzymes in
blood and liver (8). Issues insufficiently
explored are fetal vulnerability and the
ability of maternal detoxification and pla-
cental barriers to offer meaningful protec-
tion in utero. Meanwhile, it is becoming
clear that anticholinesterase toxicity may
directly or indirectly affect a variety of
neural systems. Song et al. (9) found that
chlorpyrifos in a subtoxic dose (1 mg/kg,
subcutaneously) caused no mortality or
weight loss in neonatal rats but inhibited
brain AChE activity by 25%. Although the
inhibition recovered within a few days, it
was followed by sizeable reductions of
adenylyl cyclase expression in several brain
regions. G-protein linked signaling cas-
cades were also impaired. Chlorpyrifos may
therefore be able to disturb multiple neuro-
transmitter pathways in the developing
central nervous system.
Despite these indications of acute
susceptibility to anticholinesterases, it is
only fair to point out that AChE activity in
younger animals typically recovers quickly
and drops less than in adults when subtoxic
doses are repeated (3,4). Such observations
probably reflect a relatively robust turnover
Environmental Health Perspectives * Vol 107, Supplement l * February 1999 59BRIMUOIN AND KOENIGSBERGER
ofAChE in the immature organism, where
rapid protein synthesis speedily replaces
inactivated enzyme. Even so, the collective
animal data justify continued attention to
the risks of anticholinesterase toxicity in
human infants. The toxicologic rationale is
further strengthened by new data suggest-




In the classical view, AChE has evolved to
regulate cholinergic neurotransmission by
hydrolyzing synaptic acetylcholine, whereas
BChE represents a less important enzyme
with an uncertain role in metabolizing xeno-
biotic esters. Consistent with this view,
AChE predominates in neurons and muscle
cells wherever cholinergic synapses are
found. BChE on the other hand occurs pri-
marily in nonneural or nonsynaptic sites like
liver, lung, plasma, and neuroglia. But the
full picture is more complex, since AChE
also occurs in nonneural and embryonic tis-
sues like red blood cells, megakaryocytes,
and migrating neural crest cells. Similarily,
BChE appears in limited groups ofneurons
(10,11), although its physiologic function at
such sites is unknown (12).
The wide cellular distributions ofAChE
and BChE have fueled speculation that
cholinesterases function in ways unrelated to
cholinergic neurotransmission-a topic of
several current reviews (13,14). Proposed
noncholinergic roles for AChE range from
neuromodulation by secreted forms (15,16)
to promotion ofcell proliferation in tumor
growth and hematopoiesis (17,18). It has
also been suggested that AChE facilitates
axonal outgrowth and synapse formation, in
otherwords, that it serves as a "morphogenic
molecule" in neurons (19). Ifthis suggestion
is valid, then we must consider whether anti-
cholinesterase pesticides might harm imma-
ture organisms byhindering the architectural
development oftheir nervous systems. That
is admittedly a speculative proposition, espe-
cially when it involves judging the risks of
low level environmental exposures. The
point is, however, that more data are needed
on the involvement ofAChE in neural
development and the potential influence of




One reason to suspect a developmental role
for AChE is the growth-related shift in
molecular forms generated by alternative
3'-mRNA splicing. The developing brain
is rich in monomeric and dimericAChE-
forms that are mainly intracellular
(19-21). Adult brain AChE, however,
occurs mostly as tetramers anchored to the
outer neuronal surface by a hydrophobic
peptide. Transition from small intracellular
to large extracellular AChE forms occurs
during and after synapse formation (20).
The meaning ofthis shift is unclear, but it
might relate to a transition between two
roles: first in generating and stabilizing
synaptic structures, then in promoting
synaptic function.'
The strongest circumstantial evidence
for a morphogenic role ofAChE lies in the
timing ofenzyme expression and axonal
outgrowth. Neural AChE typically appears
while axons are growing and before synaptic
connections form (21). Thalamocortical
projection neurons ofthe neonatal rat brain
provide a particularly striking example.
These sensory relay neurons are neither
cholinergic nor cholinoceptive, and they
express virtually no AChE in either the
embryonic or the mature state. Nonetheless,
they begin exhibiting intense AChE activity
shortly after birth, then cease again within
another 2 to 3 weeks. This transient AChE
expression coincides with the period when
thalamic axons (from medial and lateral
geniculate, ventral posterolateral and ventral
posteromedial nuclei) are growing into pri-
mary sensory cortex (22-24). Similar corre-
lations of axonal growth and enzyme
expression appear in other systems, includ-
ing the developing human brain (25).
Therefore, we suggest that transient AChE
expression is no accident ofdevelopment,
but a means ofpromoting axonal outgrowth
orsynaptic connection.
Developmental patterns ofcholinesterase
expression are most thoroughly documented
in avian nervous systems. Layer and co-
workers (14,26) showed that a switch from
BChE expression to AChE expression in
embryonic chick cultures regularly accom-
panies the switch from cell proliferation to
neural differentiation. In other words, neu-
roblasts express BChE as they cease divid-
ing, but committed neurons express AChE
as they generate axonal processes. Mutually
exclusive spatiotemporal expression of
AChE and BChE also occurs in vivo. For
example, during limb formation in later-
stage chick embryos, long efferent nerve
fibers originate from AChE-rich areas and
grow through Schwann cell-lined pathways
foreshadowed by BChE expression (27).
Similarly, during ontogenesis of muscle
tissue, motor neurons emerging from the
neural tube express AChE as they extend
toward the myotome through BChE-
positive sclerotomal space (26,28). BChE
thus precedes AChE in neurons and along
the trajectory oftheir axons, which suggests
a coordinated but reciprocal regulation of
these two enzymes.
Data also support a developmentally
regulated switch from BChE to AChE
expression in spinal sensory or dorsal root
ganglia (DRG). The DRG form a chain
within the vertebral column beside the
spinal cord. Each ganglion consists of
pseudo-unipolar sensory neuronal cell bod-
ies and satellite (glial) cells. Although the
ganglia have no synapses of any kind, all
neuronal subpopulations express the full
range of cholinergic markers, including
choline acetyltransferase (29-31). In
embryonic chick DRG, total AChE activity
per ganglion accumulates steadily with
increasing age, but specific AChE activity
(units/milligram) rises to a peak at gesta-
tional day 12 and then slowly declines to
the adult level (32). In contrast, BChE
activity begins high and then drops quickly
as the DRG mature (14,19). There is a
similar pattern ofexpression in the rat (33).
At embryonic day 9 (E9), before DRG are
formed, the neural tube stains heavily for
BChE activity (Figure 1). In early DRG as
well (El 1-12), quantitative video micro-
scopy shows prominent BChE activity
whileAChE activity is barely evident. From
E13 on, however, AChE activity pre-
dominates and reaches high levels in the
neuronal cell bodies. At these later stages
BChE activity disappears from neurons but
becomes highly expressed in glial cells of
the surrounding neuropil and ganglionic
roots. This distribution ofcholinesterases
resembles the adult pattern. Not surpris-
ingly, AChE mRNA levels, as determined
by polymerase chain reaction (PCR) assay
from DRG collected at days E12-E19, vary
in parallel with the intensity of enzyme
stain. These temporal changes imply that
AChE is a postmitotic differentiation
mariker that replaces BChE in sensory
neuronswhen cell proliferation is complete.
Molecules Affecting
Neurite Outgrowth
When AChE was cloned from Torpedo
(34), mouse (35), and human sources
(36), surprising sequence homologies came
to light, with certain molecules implicated
in morphogenic phenomena. Perhaps more
than any other discovery, this observation
has driven research into potential develop-
mental functions of the cholinesterases.
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Morphogenic proteins are classified
according to mechanism of action and
shared protein motifs. The most interesting
molecules from our standpoint are those
with homology to AChE, such as glutactin,
neurotactin, gliotactin, and neuroligin.
These nonenzymatic proteins belong to the
broadly defined serine esterase domain
family. They are all extracellular matrix
components that influence cell-cell inter-
actions by promoting cell adhesion. A
dendrogram ofserine esterase domain pro-
teins with defined adhesive functions
(Figure 2) illustrates their relationship to
each other and to cholinesterases from rep-
resentative species. Although the adhesive
proteins are catalytically inactive, their
sequence similarities with AChE range
from 42 to 60% (Table 1). Conserved
regions, including those that flank the
"missing" catalytic serine, may be key to
unraveling the morphogenic properties of
this family.
Glutactin, neurotactin, and gliotactin
are Drosophila proteins, at least two of
which resemble AChE in showing transient
expression during key stages in develop-
ment. Glutactin is a secreted basement
membrane glycoprotein of unknown func-
tion. Neurotactin is a transmembrane glyco-
protein, transiently expressed on the surface
ofdifferentiating neuronal and epithelial
cells (36). A three-dimensional model pre-
dicts that neurotactin's N-terminal domain
is structurally similar to Torpedo AChE,
although the topology ofmembrane anchor-
ing is different. In vitro studies with trun-
cated neurotactin show that the extracellular
region is critical for adhesive functions.
When this region was replaced with the
homologous domains from Torpedo AChE,





Figure 1. AChE and BChE enzyme activity in representative DRG. Enzymatically stained cryostat sections from rat
embryos at embryonic days 9 (E9) to 17 (El7). Top panels show predominance of BChE in neural tube. After onset
of neural differentiation (E13), BChE staining declines transiently and AChE staining increases markedly, starting
in the ventral pole of the DRG. Later, AChE activity spreads throughout the DRG neurons, and BChE activity
returns, but mostly in the roots and neuropil. From Koenigsberger et al. (33), with permission of Elsevier Science
Publishers. Scale bar=250 pm.
chimeric neurotactin still supported cell
adhesion in transfected S2 cells (37).
However, full-length glycophospholipid-
anchored dimers ofd-AChE did not sup-
port adhesion on their own (38). Therefore,
neurotactin's ability to promote cell-cell
interactions may require participation from
cytoplasmic and transmembrane domains,
which are ofcourse lacking inAChE.
Another example ofa cholinesterase-like
molecule with structurally based mor-
phogenic properties is gliotactin, a tran-
siently expressed transmembrane protein in
peripheral glia of Drosophila. Gliotactin
may participate in cell-cell interactions that
help glia to envelop nearby axons and form
a tight blood-nerve barrier (39). Glio-
tactin-knockout insects have an intact
peripheral nervous system, but the
blood-nerve barrier does not form prop-
erly. This deficiency exposes nerves to high
extracellular K+, leading to paralysis and
other physiologic abnormalities.
Neuroligins also have significant
homology to AChE (Table 1) and a
potential, indirect role in cell-cell inter-
action. Rat neuroligin-1 (40) is a ligand
for 1-neurexins, putative neuronal surface
receptors believed to contribute to synaptic
organization. Studies ofDrosophila mutants
show that glial neurexin participates in
forming.the blood-brain barrier. Lack of
neurexin expression causes defects similar to
those in gliotactin knockouts (41).
Interestingly, neurexin binds protein 4.1,
an intracellular ligand that promotes inter-















Figure 2. Relationships among selected members of
the serine esterase domain family. This dendrogram
was generated on the basis of primary amino acid
sequence identity using the PileUp program (55).
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Table 1. Serine esteraselike proteins compared by percentage identity and similarity.)
Identity, % (similarity, %)
r-AChE m-BChE d-AChE r-Neur d-Glio d-Glut d-Nrta
52 (62) 40 (47) 38 (48) 34 (42) 36(45) 42 (49)
m-BChE - 38 (65) 33 (60) 31 (56) 24 (53) 25 (55)
d-AChE - 30 (60) 26 (58) 23 (56) 22 (54)
r-Neuroligin-1 - 29 (58) 25 (53) 16 (43)
d-Gliotactin - 20 (50) 24 (54)
d-Glutactin - 19 (51)
d-Neurotactin
Abbreviations: r, rat, d, Drosophila; m, mouse. aCalculations used the BestFit program (55). Comparisons with
AChE were based on the extracellular domains of the homologous proteins. Cross-comparisons among gliotactin,
glutactin, neurotactin, and neuroligin were based on entire amino acid sequences.
and the cytoskeleton in erythrocytes (42).
Members ofthe 4.1 family are also expressed
in vertebrate brain (41). Neuroligins can
therefore be linked to important pathways of
cellular communication and adhesion in the
nervous system.
Still other morphogenic molecules
show a different type of homology with
cholinesterases through common patterns
ofglycosylation. For example, the carbohy-
drate HNK-1 epitope is found on AChE in
addition to myelin-associated glycoprotein,
NCAM, LI, and members of the tenascin
family (43-46). Although HNK-1 is not a
unique marker for cell-adhesion proteins,
this shared occurrence provides yet another
reason to hypothesize that AChE itself
engages in protein-protein interactions.
Experimental Test of
Developmental Role
Having surveyed the circumstantial evidence
that AChE is involved in neural develop-
ment, we can now consider the results of
experiments designed to test this hypothesis.
Most of the early attempts along these lines
were pharmacologic. That is, various anti-
cholinesterases were examined in neuronal
culture to determine whether enzyme inhi-
bition led to abnormal differentiation and
outgrowth ofaxons. Unfortunately, few pes-
ticides or environmentally relevant toxicants
were selected for study, but generic agents
have helped to clarify morphogenic roles
and mechanisms.
A consistent finding by several research
groups concerns morphogenic effects of
BW284c51 [1,5-bis(4-allydimethylam-
moniumphenyl)pentan-3-one dibromide],
a selective, rapidly reversible, bis-quater-
nary AChE inhibitor. This agent strongly
suppresses neurite outgrowth in several
model systems, including cultured chick
neurons (47), and cultured rat DRG (48).
In our laboratory, that effect was replicated
in differentiating murine neuroblastoma
cells (49) as well as rat DRG (50). The
morphologic effects of BW284c51 cannot
be solely due to AChE inhibition, because
equally potent AChE inhibitors like
echothiophate do not affect neurite out-
growth in vitro (47,49,50) or in neonatal
rats (51). Such results do not necessarily
mean that the drug effects are nonspecific.
As Bigbee argues (52), interaction ofbulky
ligands with AChE, especially at the
peripheral site, may distort protein shape
or surface charge. That could in turn dis-
turb critical protein-protein interactions,
including those of an adhesive nature.
Therefore, the pharmacologic data lead
naturally to the hypothesis that AChE's
morphogenic functions need not involve
catalytic activity at all. In other words, the
critical property may be structure.
To explore a structural role forAChE in
neural differentiation, one requires a system
in which AChE protein levels can be modu-
lated, preferably in both directions. Seeking
a convenient, isolated system in which
acetylcholine hydrolysis should not be a fac-
tor, we selected the differentiating NIE.1 15
cell. This murine neuroblastoma cell line is
classified as adrenergic (expressing tyrosine
hydroxylase, not choline acetyltransferase),
but it exhibits moderate levels ofAChE
activity. Upon serum deprivation, most
NIE.1 15 cells extend neurites whose rate of
outgrowth can be easily measured.
First, we demonstrated that AChE
expression in wild-type NIE.1 15 cells could
be transiently downregulated with antisense
oligonucleotides (49). Next, to enhance the
underexpression and make it permanent, we
engineered stable transfectants to express
antisense AChE cDNA under the direction
ofa f3-actin promoter. AChE overexpressors
were also created by stable transfection of
full length sense AChE cDNA. In all, we
produced six antisense lines, seven sense
lines, and one control line (empty vector
transfection). The relationship between
AChE expression in these cells and their
ability to differentiate inito a clearly neuronial
phenotype was then characterized.
In data pooled from all cell lines, AChE
enzyme activity correlated strongly with
mRNA level as determined by Northern blot
analysis (r =0.98). On average, cells stably
transfected with sense AChE cDNA
increased their AChE expression (enzyme
activity and mRNA level) 2.5-fold over wild
type. Increased amounts of immunoreactive
Tau protein, a neuronal differentiationl
marker, rose as well, and the sense-tran.s-
fectants displayed significantly gi-eater
neurite outgrowth (Figure 3). In conitrast,
antisense cell lines exhibited half the wild-
type level ofAChE activity (and mRNA),
lower levels ofTau, and decreased neurite
outgrowth. Overall, the rate of neurite
outgrowth correlated strongly with the
AChE level (r = 0.94). This correlation is
good evidence that AChE expression directly
or indirectly facilitates the genesis ofaxons in
differentiating nerve cells. If that view is
correct, and if the effect depends on
protein-protein interaction or adhesive
functions, one would make two predictions:
a) some AChE should localize to the exter-
nal surfaces of neural growth cones, and b)
anti-AChE antibodies that bind external
enzyme should impair neurite outgrowth.
Confirming these predictions, a polyclonal
antibody against AChE bound selectively to
the surface ofAChE-overexpressing cells and
caused a 43% decrease in neurite outgrowth
(49). Bigbee (52) recently reported even
stronger antibody-mediated suppression of
neurite extension in cultured rat DRG.
Other investigators have also obtained
evidence that AChE promotes neural
growth and differentiation by non-
enzymatic means. For example, Small (53)
reported that substrata containing native
and irreversibly inactivated AChE were
equally good in stimulating neurite elon-
gation, although heparan sulfate pro-
teoglycans had to be present as well.
Similarly, Soreq's group found that
increased process extension in glioma cells
overexpressing various AChE constructs
bore no relation to hydrolytic activity
(54). Taking the information together, it
seems that AChE's role in neural differen-
tiation is more likely to involve structural
than catalytic mechanisms.
Conclusion
Evidence is rapidly mounting that
cholinesterases have a role in neural develop-
ment: a) AChE is surprisingly homologous
to proven morphogenic molecules. b) In
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both mammals and birds, a developmen-
tally regulated switch from BChE to
AChE expression coincides with the onset
of neural differentiation. c) Transient
AChE expression in many neural pathways
corresponds closely to the period ofaxonal
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outgrowth. d) Large, inhibitory effects on
neurite outgrowth can be caused by in vitro
exposure to certain anticholinesterases, par-
ticularly those such as BW284c51, capable
ofinteracting with AChE's peripheral site.
e) Neurite outgrowth and other measures
ofdifferentiation are enhanced in neuronal
lines that overexpress AChE and depressed
in lines that underexpress AChE.f) Specific
AChE antibodies interfere with extension of
neural processes after binding to external
cell surfaces in culture.
This growing body of knowledge is
exciting to neurobiologists. There are also
important toxicologic implications. Alth-
ough AChE may affect morphogenesis by
noncatalytic mechanisms such as structural
recognition, these mechanisms could cer-
tainly be vulnerable to pesticides. Any anti-
cholinesterase that might alter AChE's
steric or electrostatic properties should be
suspected as agrowth inhibitor until proved
innocent. Agents acting at the peripheral
site ofthe enzyme deserve special scrutiny.
Most pesticides fall outside this category.
However, the toxicologic data reviewed
earlier indicate that those agents may have
additional actions that would be deleterious
to a growing nervous system. It seems wise
to re-evaluate the developmental risks of
anticholinesterases as data become avail-
able from ongoing studies of environ-
mentally relevant molecules in neuronal
culture and sensitive embryologic models of
neural development.
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